Skandinaviska Enskilda Banken AB (publ) - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 112 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2020. The put-call ratio across all filers is 1.13 and the average weighting 0.3%.

Quarter-by-quarter ownership
Skandinaviska Enskilda Banken AB (publ) ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q2 2023$3,029
-63.0%
123,500
-64.9%
0.02%
-64.9%
Q1 2023$8,179
-27.2%
351,500
-20.8%
0.06%
-32.1%
Q4 2022$11,228
+40.4%
443,600
+201536.4%
0.08%
Q3 2020$8,000
-11.1%
2200.0%0.00%
Q2 2020$9,000
+12.5%
2200.0%0.00%
Q1 2020$8,0002200.00%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q2 2020
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,559,142$14,609,16117.42%
SB INVESTMENT ADVISERS (UK) LTD 16,684,041$156,329,4641.29%
Octagon Capital Advisors LP 325,050$3,045,7190.47%
SECTOR GAMMA AS 148,538$1,391,8010.36%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 1,345,635$12,608,6000.31%
ALGERT GLOBAL LLC 449,685$4,2140.20%
Quantamental Technologies LLC 18,519$173,5230.16%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 47,000$439,9200.15%
DUALITY ADVISERS, LP 123,871$1,160,6710.14%
Empowered Funds, LLC 385,135$3,608,7150.11%
View complete list of VIR BIOTECHNOLOGY INC shareholders